跳至主要内容
临床试验/NCT05990478
NCT05990478撤回不适用

Contrast-Enhanced Mammography With Early and Delayed Acquisitions in the Assessment of the Extent of Residual Disease Following Neoadjuvant Treatment in Patients With Breast Cancer

Memorial Sloan Kettering Cancer Center0 个研究点开始时间: 2023年8月3日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Compare the sensitivity and specificity of Contrast-Enhanced Mammography/CEM with standard 'early' acquisition to CEM with delayed acquisition

研究概览

简要总结

The purpose of this study is to find out whether Contrast-Enhanced Mammography/CEM scans performed 2 minutes and 6 minutes after receiving Iohexol contrast dye can be used to identify the amount of residual disease in the breast following neoadjuvant treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Any women >18 years of age at time of informed consent
  • Diagnosed with breast cancer and schedule for NAT

排除标准

  • History of kidney disease, creatinine level >1.3 or eGFR <
  • Known allergic reaction to gadolinium or iodinated contrast media.
  • Contraindication to contrast-enhanced breast MRI.
  • Lesion not included in the field of view of either pre- or post-NAT MRI or CEM
  • Presence of pacemakers or automated implantable cardioverter defibrilator
  • Pregnant women

结局指标

主要结局

Compare the sensitivity and specificity of Contrast-Enhanced Mammography/CEM with standard 'early' acquisition to CEM with delayed acquisition

时间窗: Up to 1 year

compare the sensitivity and specificity of CEM with standard 'early' acquisition to CEM with delayed acquisition, in detecting breast cancer lesions with pathological complete response (pCR) after NAT.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验